Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of Suzi Apu tablets for non-segmental vitiligo
CTR20213317Phase 3Active
- Sponsor
- Xinjiang Huakang Pharmaceutical
- Start
- Apr 2022
- Countries
- 1
01
Overview
A Phase 3 trial of Suzi Apu in Vitiligo, sponsored by Xinjiang Huakang Pharmaceutical. Started Apr 2022; status: active.
02
Drugs
Suzi Apu
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20213317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213317.